Alfonso R. Paulete-Sanchez

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth.

Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth.

Journal: Cancer cell
Published: March 27, 2025

TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer.

TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer.

Journal: Nature immunology
Published: June 30, 2022

Targeting Macrophages with CAR T Cells Delays Solid Tumor Progression and Enhances Antitumor Immunity.

Targeting Macrophages with CAR T Cells Delays Solid Tumor Progression and Enhances Antitumor Immunity.

Journal: Cancer immunology research
Published: December 16, 2021

DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells.

DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells.

Journal: Journal for immunotherapy of cancer
Published: March 23, 2021

Cellular cytotoxicity is a form of immunogenic cell death.

Cellular cytotoxicity is a form of immunogenic cell death.

Journal: Journal for immunotherapy of cancer
Published: March 01, 2020

Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses.

Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 21, 2019

Repurposing the yellow fever vaccine for intratumoral immunotherapy.

Repurposing the yellow fever vaccine for intratumoral immunotherapy.

Journal: EMBO molecular medicine
Published: January 25, 2019

Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells.

Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells.

Journal: Cancer cell
Published: December 22, 2018

Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming.

Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming.

Journal: Cancer research
Published: March 28, 2018

Mitochondrial Morphological and Functional Reprogramming Following CD137 (4-1BB) Costimulation.

Mitochondrial Morphological and Functional Reprogramming Following CD137 (4-1BB) Costimulation.

Journal: Cancer immunology research
Published: December 29, 2017

Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.

Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 19, 2017

Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.

Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 26, 2017
Showing 1-12 of 24

Last Updated: 09/26/2026